Rutgers Cancer Institute of New Jersey: Germline Testing - Exploring How DNA Impacts Cancer Risk and Treatment
November 18, 2021
November 18, 2021
NEW BRUNSWICK, New Jersey, Nov. 18 (TNSJou) -- Rutgers Cancer Institute of New Jersey issued the following news:
Germline testing checks an eligible person's DNA for genetic inherited mutations that could potentially increase the risk of developing cancers or other health problems. Researchers from Rutgers Cancer Institute of New Jersey and Dana-Farber Cancer Institute developed and evaluated a computational pipeline that utilizes information commonly provided in academic and c . . .
Germline testing checks an eligible person's DNA for genetic inherited mutations that could potentially increase the risk of developing cancers or other health problems. Researchers from Rutgers Cancer Institute of New Jersey and Dana-Farber Cancer Institute developed and evaluated a computational pipeline that utilizes information commonly provided in academic and c . . .